Transplantation / Projects

3rd Health Programme (2014-2020)
Equal access for all patients to high quality cells for transplantation [SAVDON]
WMDA strives that patients worldwide have equal access to high quality cells for transplantation from donors whose rights and safety are protected. To achieve this the WMDA has implemented a strategic...
WMDA strives that patients worldwide have equal access to high quality cells for transplantation from donors whose rights and safety are protected. To achieve this the WMDA has implemented a strategic plan for the years 2018-2021.
As an organisation that exists to achieve the best for stem cell donors and transplant patients, the strategy has been co-created with affiliate organisations. The strategy aims to deliver impact in the following areas:
- Optimising ‘search, match and connect’
- Supporting global development
- Promoting donor care
- Ensuring quality

The WMDA aims to facilitate the best possible stem cell source for transplant patients, while the rights and safety of the donors are promoted and protected. This is achieved by:
- setting up a good infrastructure to facilitate communication
- developing education programmes to share best practices
- maintain a platform to report serious adveres events and reactions in as well donors as patients
- promote accreditation and standardisation through the accreditation programme



Start date: 01/01/2020 - End date: 31/12/2020

Call: Financial Contribution to the Functioning of Non-Governmental Bodies - Invitation to submit proposals for Specific Operating Grant Agreements (SGA)
Topic: Transplantation
3rd Health Programme (2014-2020)
ERN in Transplantation in Children (SOT HSCT) [ERN TRANSPLANTChild]
The paediatric transplantation (of solid organs and hematopoietic progenitors) has increased survival in children with end-stage disease, becoming one of the main treatment options for this population...
The paediatric transplantation (of solid organs and hematopoietic progenitors) has increased survival in children with end-stage disease, becoming one of the main treatment options for this population. However, there are significant challenges associated with optimising the effects of these interventions:
i)The mechanisms associated with tolerance to graft rejection;
ii) The pre-transplant -and surgical techniques and care procedures; ii) post-transplantation care;
iii) The specificities associated with this population group and type of disease;
iv) The social and economic impact of these surgeries on patients, their families and health systems.
Since these factors are key to the success of the process and a common link in various types of transplantations, there is a need to implement and standardise recent improvements in this field for routine use, directing them towards prevention, improvement of the surgical procedures themselves, treatment of chronicity and the appearance of secondary diseases associated with transplantation.
As a result of these activities, the paediatric transplantation network will achieve to increase life expectancy and quality of life of paediatric patients requiring a solid organ or hematopoietic progenitor transplantation and their families, and will provide added value,
Start date: 01/03/2017 - End date: 28/02/2018

Call: EUROPEAN REFERENCE NETWORKS SPECIFIC GRANT AGREEMENTS COVERING YEAR 2017
Topic: Transplantation
3rd Health Programme (2014-2020)
European Rare Kidney Diseases Reference Network [ERKNet]
The European Reference Network for Rare Kidney Diseases (ERKNet) will offer highly specalised healthcare to children and adults suffering from congenital and acquired glomerulopathies, tubulopathies, ...
The European Reference Network for Rare Kidney Diseases (ERKNet) will offer highly specalised healthcare to children and adults suffering from congenital and acquired glomerulopathies, tubulopathies, metabolic and stone forming nephropathies, thrombotic microangiopathies, renal ciliopathies and other anomalies of kidney and urinary tract development.
The Network comprises almost 40 centres in 12 European countries with specific expertise documented by large patient numbers (collectively more than 45,000), state-of-art diagnostic services and therapeutic equipment and professional multidisciplinary care.
The Members will share best practices by offering physical and virtual cross border consultation, series of educational workshops and webinars, e-learning modules on focused rare kidney disease topics, short-term training opportunities, and by endorsing existing and developing new clinical practice guidelines and recommendations wherever needed. In collaboration with the patient organisations, the Network will collect informational materials on all rare kidney diseases and their treatments and make the documents available in multiple languages to affected families throughout Europe.
Furthermore, ERKNet will strive to harmonize and further optimize patient care across the Member centres by regularly monitoring and benchmarking guideline adherence, disease-specific performance and outcomes measures, as well as patient safety and satisfaction.
Another important goal of the Network will be to actively support clinical research into risk factors and biomarkers of early and severe disease phenotypes, and provide a platform for innovative interventional clinical trials aimed at improving or stabilizing kidney functions and preventing progressive renal failure in adults and children with rare kidney diseases.
Start date: 01/03/2017 - End date: 28/02/2018

Call: EUROPEAN REFERENCE NETWORKS SPECIFIC GRANT AGREEMENTS COVERING YEAR 2017
Topic: Transplantation
3rd Health Programme (2014-2020)
European Rare Kidney Diseases Reference Network [ERKNet]
The European Reference Network for Rare Kidney Diseases (ERKNet) will offer highly specalised healthcare to children and
adults suffering from congenital and acquired glomerulopathies, tubulopathies, ...
The European Reference Network for Rare Kidney Diseases (ERKNet) will offer highly specalised healthcare to children and
adults suffering from congenital and acquired glomerulopathies, tubulopathies, metabolic and stone forming nephropathies,
thrombotic microangiopathies, renal ciliopathies and other anomalies of kidney and urinary tract development.
The Network comprises almost 40 centres in 12 European countries with specific expertise documented by large patient
numbers (collectively more than 45,000), state-of-art diagnostic services and therapeutic equipment and professional
multidisciplinary care.
The Members will share best practices by offering physical and virtual cross border consultation, series of educational
workshops and webinars, e-learning modules on focused rare kidney disease topics, short-term training opportunities, and
by endorsing existing and developing new clinical practice guidelines and recommendations wherever needed. In
collaboration with the patient organisations, the Network will collect informational materials on all rare kidney diseases and
their treatments and make the documents available in multiple languages to affected families throughout Europe.
Furthermore, ERKNet will strive to harmonize and further optimize patient care across the Member centres by regularly
monitoring and benchmarking guideline adherence, disease-specific performance and outcomes measures, as well as
patient safety and satisfaction.
Another important goal of the Network will be to actively support clinical research into risk factors and biomarkers of early
and severe disease phenotypes, and provide a platform for innovative interventional clinical trials aimed at improving or
stabilizing kidney functions and preventing progressive renal failure in adults and children with rare kidney diseases.
Start date: 01/03/2018 - End date: 28/02/2019

Call: EUROPEAN REFERENCE NETWORKS SPECIFIC GRANT AGREEMENTS COVERING YEAR 2018
Topic: Transplantation
3rd Health Programme (2014-2020)
3rd to 5th annual work program ERN TransplantChild [ERN TransplantChild]
3rd - 5th Annual Work Program for the ERN TransplantChild - Transplantation in Children, both Solid Organ Transplantation
and HSCT
Description of activities planned for the developement by the coordi...
3rd - 5th Annual Work Program for the ERN TransplantChild - Transplantation in Children, both Solid Organ Transplantation
and HSCT
Description of activities planned for the developement by the coordination of the third to fifth year of the ERN TransplantChild. 18 Health Care Providers from 11 different European countries
The general objectives are:
A. The identification of key aspects for the complete development of the Network and the development of actions for the joint achievement of the Network objectives:
B. The support and coordination of the Network activities.

The outputs we plan to obtain are related to report and analysis of key aspects related to paediatric transplantation, with a great impact in patients, families and professionals involved in the care of this patients.
Start date: 01/03/2019 - End date: 28/02/2022

Call: Multiannual Grant Agreements for European Reference Networks
Topic: Transplantation